Seroprevalence of Helicobacter pylori and association with atrophic gastritis in patients with Sjögren’s syndrome

REFERENCES

• Maury CPJ, Tornroth T, Teppo A-M et al, Atrophic gastritis in Sjogren’s syndrome. Morphologic, biochemical, and immunologic findings, Arthritis Rheum 28, 388–394 (1985).
   PubMedGoogle Scholar
• Pokorny Gy, Karacsony G, Lonovics J et al, Type of atrophic gastritis in patients with primary Sjogren’s syndrome, Ann Rheum Dis 50, 97–100 (1991).
   PubMed Web of Science ®Google Scholar
• Collin P, Karvonen A-L, Koppela M et al., Gastritis classified in accordance with the Sydney system in patients with primary Sjogren’s syndrome, Scand J Gastroenterol 32, 108–111 (1997).
   PubMed Web of Science ®Google Scholar
• Fukuda H, Saito D, Hayashi S et al, Helicobacter pylori infection, serum pepinogen level and gastric cancer: a case-control study in Japan, Jpn J Cancer Res 86, 64–71 (1995).
   PubMedGoogle Scholar
• Asaka M, Kimura T, Kudo M et al, Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population, Gastroenterology 102, 760–766 (1992).
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ozawa K, Higashi A et al, Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan, J Clin Gastroenterol 25, 391–394 (1997).
   PubMed Web of Science ®Google Scholar
• Samloff IM, Variss K, Ihamaki T et al, Relationship among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology, Gastroenterology 83, 204–209 (1982).
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Uyterlinde AM, Pena AS et al, Long-term sequelae oí Helicobacter pylori gastritis, Lancet 345, 1525–1528(1995).
   PubMed Web of Science ®Google Scholar
• Siman JH, Forsgren G, Berglund G et al, Association between Helicobacter pylori and gastric carcinoma in city of Malmo, Sweden. A prospective study, Scand J Gastroenterol 32, 1215–1221 (1997).
   PubMed Web of Science ®Google Scholar
• Wang WM, Chen CY, Jan CM et al, Long-term follow-up and serological study after triple therapy of Helicobacter /?v/on-associated duodenal ulcer, Am J Gastroenterol 89, 1793–1796 (1994).
   PubMed Web of Science ®Google Scholar
• Miki K, Basic evaluation of pepsinogen EIA kit, Igaku to Yakugaku 37, 1013–1021 (1997) (in Japanese).
   Google Scholar
• Miki K, Ichinose M, Ishikawa K et ai, Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer, Jpn J Cancer Res 84, 1086–1090 (1993).
   PubMedGoogle Scholar
• Mantel N, Haenzel W, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother Rep 50, 163- 170 (1966).
   Google Scholar
• Matsumoto K, Konishi N, Ohshima M et al., Association between Helicobacter pylori infection and serum pepsinogen concentrations in gastroduodenal disease, J Clin Pathol 49, 1005–1008 (1996).
   Google Scholar
• Evans DJ, Evans JDG, Graham DY et al., A sensitive and specific serological test for detection of Campylobacter pylori infection, Gastroenterology 96, 1004–1008 (1989).
   PubMed Web of Science ®Google Scholar
• Crabtree JE, Shallcross TM, Heatley RV et ai, Evaluation of a commercial ELISA for serodiagnosis of Helicobacter pylori infection, J Clin Pathol 44, 326–328 (1991).
   PubMed Web of Science ®Google Scholar
• Culter AF, Havstad S, Ma CK et al. Accuracy of invasive and noninvasive tests to diagnose Helicobacter pylori infection, Gastroenterology 109, 136–141 (1995).
   Google Scholar
• Misawa K, Kumagai T, Shimizu T et al, A new histological procedure for réévaluation of the serological test for Helicobacter pylori, Eur J Clin Microbiol Infect Dis 17, 14–19 (1998).
   Google Scholar
• Miki K, Ichinose M, Shimizu A et al., Serum pepsinogens as a screening test of extensive chronic gastritis, Jpn Soc Gastroenterol 22, 133–141 (1987).
   PubMedGoogle Scholar
• Inoue M, Kobayashi S, Matsuura A et al, Agreement of endoscopic findings and serum pepsinogen levels as an indicator of atrophic gastritis. Cancer Epidem Biomark Prevent 1, 261–263(1998).
   Google Scholar
• Dooley CP, Hartley C, Fitzgibbons PI et al, Prevalence oi Helicobacter pylori infection and histologic gastritis in asymptomatic persons, N Engl J Med 321, 1562–1566 (1989).
   PubMed Web of Science ®Google Scholar
• Graham DY, Malaty HM, Evans DG et al. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status, Gastroenterology 100, 1495–1501 (1991).
   Google Scholar
• Shoji Y, Nozawa R, Sato K et al, Seroprevalence oi Helicobacter pylori infection in patients with connective tissue diseases, Microbiol Immunol 40, 499–503 (1996).
   Google Scholar
• Taha AS, Sturrock RD, Russell RI, Helicobacter pylori and peptic ulcers in rheumatoid arthritis patients receiving gold, sulfasalazine and nonsteroidal anti-inflammatory drugs, Am J Gastroenterol 87, 1732–1735 (1992).
   PubMed Web of Science ®Google Scholar
• Mizokami Y, Tamura K, Fukuda Y et al. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori, Eur J Gastroenterol Hepatol 6 (suppl. I), S109-S112 (1994).
   Google Scholar
• Ostuni PA, Germana B, Mario FD et al, Gastric involvement in primary Sjogren’s syndrome, Clin Exp Rheumatol 11, 21–25 (1993).
   PubMed Web of Science ®Google Scholar
• Sugaya T, Sakai H, Sugiyama T et al. Atrophic gastritis in Sjogren’s syndrome, Nihon Rinsho 53, 2540–2544 (1995) (in Japanese).
   Google Scholar
• Salvatore DV, Boiocchi M, Sorrentino D et al, Characterization of prelymphomatous stages of B cell lymphoproliferation in Sjogren’s syndrome, Arhritis Rheum 40, 318–331 (1997).
   Google Scholar
• Haeji N, Nakamura T, Takio K et al, Identification of a-fodrin as a candidate autoantigen in primary Sjogren’s syndrome, Science 276, 604–607 (1997).
   Google Scholar
• Garcia-Carrasco M, Ramos M, Cervera R et al, Hepatitis C virus infection in primary Sjogren’s syndrome: prevalence and clinical significance in a series of 90 patients, Ann Rheum Dis 56, 173–175(1997).
   PubMed Web of Science ®Google Scholar
• Terada K, Katamine S, Eguchi K et al., Prevalence of serum and salivary antibodies to HTLV-1 in Sjogren’s syndrome, Lancet 344, 1116–1119 (1994).
   PubMed Web of Science ®Google Scholar